382
Participants
Start Date
September 30, 2006
Primary Completion Date
September 30, 2009
Study Completion Date
September 30, 2009
IM risperidone
long-acting injectable risperidone
oral antipsychotic medication
doctor's choice (excluding other long-acting injectable medications but not specifying any particular oral agents or dosages)
New York Harbor HCS, New York
VA Medical Center, Philadelphia, Philadelphia
VA Medical Center, Augusta, Augusta
VA Medical Center, Miami, Miami
VA Medical Center, Tuscaloosa, Tuscaloosa
VA Medical Center, Cleveland, Cleveland
John D. Dingell VA Medical Center, Detroit, Detroit
VA Medical Center, Minneapolis, Minneapolis
Jesse Brown VAMC (WestSide Division), Chicago
VA Medical Center, Kansas City MO, Kansas City
Central Texas Veterans Health Care System - Waco, Waco
Michael E. DeBakey VA Medical Center (152), Houston
VA Medical Center, Long Beach, Long Beach
VA Puget Sound Health Care System, Seattle, Seattle
VA Palo Alto Health Care System, Palo Alto
VA Connecticut Health Care System (West Haven), West Haven
VA Medical Center, Jamaica Plain Campus, Boston
VA Medical Center, Omaha, Omaha
New Mexico VA Health Care System, Albuquerque, Albuquerque
US Department of Veterans Affairs
FED